15 Best Undervalued Stocks Under $50 to Invest In Now

8. Novo Nordisk A/S (NYSE:NVO)

Novo Nordisk A/S (NYSE:NVO) is one of the best undervalued stocks under $50 to invest in now. Bernstein initiated coverage of Novo Nordisk A/S (NYSE:NVO) with an Underperform rating and $175 price target on March 18. The firm told investors in a research note that the company’s earnings downgrade cycle is not over, adding that it believes Novo Nordisk’s (NYSE:NVO) catalyst path “looks bare.” It also said that the company’s weight loss drugs will underperform in the United States on lower volume share and more price deflation, contending that greater mix deterioration and margin contraction will be driven by the U.S. semaglutide compound patent expiration in 2032.

In another development, Novo Nordisk A/S (NYSE:NVO) announced on March 19 that the US Food and Drug Administration has approved Wegovy® HD to reduce excess body weight and maintain weight reduction long-term. Wegovy® HD was awarded a Commissioner’s National Priority Voucher by the FDA for accelerating its review and highlighting its potential to address critical patient needs and national health priorities in the United States.

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products.